The aim of this study was to evaluate whether the comet tail artifact on ultrasonography can be used to reliably diagnose benign gallbladder diseases. This retrospective study reviewed the clinical findings, imaging findings, preoperative ultrasonographic diagnoses, and pathological diagnoses of 150 patients with comet tail artifacts who underwent laparoscopic cholecystectomy with pathologic confirmation. The extent of the involved lesion was classified as localized or diffuse, depending on the degree of involvement and the anatomical section of the gallbladder that was involved. This study evaluated the differences in clinical and imaging findings among pathologic diagnoses. All gallbladder lesions exhibiting the comet tail artifact on ultrasound examination were confirmed as benign gallbladder diseases after cholecystectomy, including 71 cases of adenomyomatosis (47.3%), 74 cases of chronic cholecystitis (49.3%), two cases of xanthogranulomatous cholecystitis (1.3%), and three cases of cholesterolosis (2.0%); there were two cases of coexistent chronic cholecystitis and low-grade dysplasia. There were no statistically significant differences in any of the clinical and ultrasonographic findings, with the exception of gallstones (P=0.007), among the four diseases. There were no significant differences in the average length, thickness, or number of comet tail artifacts among the four diagnoses. No malignancies were detected in any of the 150 thickened gallbladder lesions. The ultrasonographic finding of the comet tail artifact in patients with thickened gallbladder lesions is associated with the presence of benign gallbladder diseases, and can be considered a reliable sign of benign gallbladder disease.
Objectives: To evaluate the diagnostic performance of automated vertebral trabecular Hounsfield unit (HU) measurements derived from routine fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) for identifying low bone density. Methods: This retrospective study included 131 consecutive women (mean age, 53.5 ± 9.6 years) undergoing health screening with FDG PET/CT and dual-energy X-ray absorptiometry (DXA) between January 2020 and December 2024. A deep learning-based model (TotalSegmentator) automatically segmented the lumbar vertebrae (L1–L4). HU-based metrics in trabecular regions were calculated, and their correlations with DXA-derived bone mineral density (BMD) were assessed. Diagnostic performance was evaluated using receiver operating characteristic analysis. A multivariable logistic regression model incorporating mean HU, age, and body mass index was developed and internally validated using bootstrap resampling. Results: According to WHO criteria, 47 of 131 participants (35.9%) had low bone density. Mean HU demonstrated strong diagnostic performance (area under the curve [95% confidence interval]: L1, 0.861 [0.800–0.923]; L2, 0.852 [0.788–0.915]; L3, 0.861 [0.800–0.921]; L4, 0.845 [0.781–0.909]). L1 mean HU provided the most balanced performance (sensitivity, 0.851; specificity, 0.750); L3 mean HU was slightly inferior. L1 mean HU was strongly correlated with BMD (r = 0.821, p < 0.001). In multivariable analysis, mean HU independently predicted low bone density (odds ratio: 0.949, p < 0.001). The model achieved an accuracy of 0.786 and demonstrated favorable calibration performance. Conclusions: The automated assessment of vertebral trabecular HU from routine FDG PET/CT provides a reliable and highly efficient method for screening low bone density without additional radiation exposure or cost.